Retirement Systems of Alabama Has $55.56 Million Stock Position in Humana Inc. (NYSE:HUM)

Retirement Systems of Alabama lifted its holdings in Humana Inc. (NYSE:HUM - Free Report) by 735.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 219,002 shares of the insurance provider's stock after purchasing an additional 192,801 shares during the quarter. Retirement Systems of Alabama owned 0.18% of Humana worth $55,563,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV grew its stake in Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock worth $27,000 after buying an additional 61 shares during the last quarter. Atwood & Palmer Inc. purchased a new stake in shares of Humana during the third quarter worth about $29,000. Ashton Thomas Securities LLC acquired a new position in Humana in the 3rd quarter valued at $31,000. Your Advocates Ltd. LLP lifted its position in Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock worth $32,000 after buying an additional 45 shares in the last quarter. Finally, LRI Investments LLC grew its position in Humana by 1,021.4% in the third quarter. LRI Investments LLC now owns 157 shares of the insurance provider's stock worth $50,000 after acquiring an additional 143 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on HUM shares. Truist Financial lifted their price objective on shares of Humana from $260.00 to $290.00 and gave the company a "hold" rating in a report on Monday, January 6th. Morgan Stanley lifted their target price on Humana from $288.00 to $301.00 and gave the company an "equal weight" rating in a research note on Tuesday, December 17th. Barclays increased their price objective on Humana from $253.00 to $255.00 and gave the stock an "equal weight" rating in a research report on Wednesday, January 22nd. Sanford C. Bernstein raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $308.00 price objective on the stock in a research note on Tuesday, October 8th. Finally, TD Cowen lifted their target price on shares of Humana from $261.00 to $268.00 and gave the stock a "hold" rating in a research note on Monday, November 4th. Nineteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Humana presently has an average rating of "Hold" and a consensus price target of $297.68.

Insider Activity

In other news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.29% of the stock is owned by insiders.

Humana Stock Performance

Shares of NYSE:HUM traded down $5.02 during trading hours on Wednesday, hitting $290.52. The stock had a trading volume of 1,102,501 shares, compared to its average volume of 1,506,460. The firm has a market capitalization of $34.98 billion, a price-to-earnings ratio of 25.73, a PEG ratio of 2.21 and a beta of 0.56. The stock's fifty day simple moving average is $275.13 and its 200 day simple moving average is $299.72. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.